Edition:
Deutschland

Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

65.96EUR
13 Dec 2019
Change (% chg)

€0.62 (+0.95%)
Prev Close
€65.34
Open
€65.88
Day's High
€66.70
Day's Low
€65.74
Volume
824,880
Avg. Vol
926,569
52-wk High
€76.68
52-wk Low
€55.44

About

Fresenius Medical Care AG & Co. KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company's segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the... (more)

Buy/Sell

Sell Hold Buy
2.16 Mean rating from 25 analysts

Overall

Beta: 0.93
Market Cap(Mil.): €19,891.21
Shares Outstanding(Mil.): 304.43
Dividend: 1.17
Yield (%): 1.79

UPDATE 3-Fresenius beats Q3 forecasts with strong sales of home dialysis treatments

* Fresenius highlights infusion drugs unit growth in emerging markets (Adds details from conference call and analyst comments, updates share price)

Photo

Fresenius beats third-quarter forecasts with strong sales of home dialysis treatments

German healthcare group Fresenius beat third-quarter revenue forecasts on Tuesday, citing a solid performance by its infusion drugs unit in emerging markets and strong growth in home treatment at its separately listed dialysis business.

German stocks - Factors to watch on October 29

BERLIN/FRANKFURT, Oct 29 The following are some of the factors that may move German stocks on Tuesday:

Fresenius Medical Care reports Q3 beat on record home dialysis in North America

Oct 29 German dialysis specialist Fresenius Medical Care reported on Tuesday a 9% rise in its third-quarter revenue, citing record growth in home dialysis in North America.

Photo

Fresenius drops possible sale of blood transfusion unit - spokesman

FRANKFURT German health care group Fresenius has abandoned plans to sell its blood transfusion business, a spokesman said on Sunday, confirming a German media report.

Fresenius drops possible sale of blood transfusion unit - spokesman

FRANKFURT, Sept 15 German health care group Fresenius has abandoned plans to sell its blood transfusion business, a spokesman said on Sunday, confirming a German media report.

German stocks - Factors to watch on August 28

BERLIN, Aug 28 The following are some of the factors that may move German stocks on Wednesday:

Fresenius Medical Care appoints Takeda executive Helen Giza as CFO

BERLIN German dialysis specialist Fresenius Medical Care has hired Helen Giza from Japan's Takeda Pharmaceutical as its new finance chief, replacing Mike Brosnan.

Fresenius Medical Care appoints Takeda executive Helen Giza as CFO

BERLIN, Aug 27 German dialysis specialist Fresenius Medical Care has hired Helen Giza from Japan's Takeda Pharmaceutical as its new finance chief, replacing Mike Brosnan.

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie +0.24%
Rohstoffe +0.50%
Industrie +0.54%
Konjunktur abhängige Waren & Dienstleistungen +0.62%
Konjunktur unabhängige Waren & Dienstleistungen +0.21%
Finanzindustrie +0.15%
Pharma +0.50%
Technologie -0.02%
Telekommunikation +1.13%

Nachrichten aus der Wirtschaft